AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
Antiretroviral Therapy
A majority of patients are diagnosed with HIV still relatively late in the disease course as defined by presenting with a very low CD4 cell count. We at this point, standard of care, we agree that if a patient is HIV positive, we're going to start antiretroviral therapy as soon as possible. Now here's a part that they presented at ID Week 2022. They actually extended this study through six-year follow-up, which ended in December of 2021. The primary composite endpoint for that original design of the trial was either serious AIDS defined as AIDS related illness or death.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode